Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-14-016382
Filing Date
2014-11-12
Accepted
2014-11-12 08:26:04
Documents
2
Period of Report
2014-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1746
2 POWER OF ATTORNEY ex24merrifield.txt EX-24 2651
  Complete submission text file 0001179110-14-016382.txt   5799
Mailing Address
Business Address
MERRIFIELD C ANN (Reporting) CIK: 0001247224 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52089 | Film No.: 141211351

Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus